These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15358178

  • 1. Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease.
    Yamagata H, Chen Y, Akatsu H, Kamino K, Ito J, Yokoyama S, Yamamoto T, Kosaka K, Miki T, Kondo I.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):320-3. PubMed ID: 15358178
    [Abstract] [Full Text] [Related]

  • 2. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT, Zhang JW, Zhang ZX, Zhao HL.
    Neurosci Lett; 2005 Oct 14; 387(1):11-6. PubMed ID: 16054753
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F.
    Exp Gerontol; 2004 Oct 14; 39(10):1567-73. PubMed ID: 15501028
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
    Koivisto AM, Helisalmi S, Pihlajamäki J, Moilanen L, Kuusisto J, Laakso M, Hiltunen M, Keijo K, Hänninen T, Helkala EL, Kervinen K, Kesäniemi YA, Soininen H.
    J Neurogenet; 2005 Oct 14; 19(3-4):155-61. PubMed ID: 16540406
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M.
    Neurobiol Aging; 2004 Sep 14; 25(8):1009-15. PubMed ID: 15212825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.
    Neurosci Lett; 2005 Feb 25; 375(1):1-6. PubMed ID: 15664112
    [Abstract] [Full Text] [Related]

  • 12. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A, ITINAD Working Group.
    Neurobiol Aging; 2009 Sep 25; 30(9):1406-12. PubMed ID: 18179845
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY, Ding JQ, Chen SD.
    J Alzheimers Dis; 2010 Sep 25; 19(4):1283-94. PubMed ID: 20061606
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F, Veglia F, Chiappelli M, Grimaldi LM, Masliah E.
    Neurobiol Aging; 2004 Sep 25; 25(8):1017-22. PubMed ID: 15212826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.